Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Five cardiac hormones decrease the number of human small-cell lung cancer cells.

B A Vesely1, S Song, J Sanchez-Ramos

  • 1Department of Internal Medicine, University of South Florida Cardiac Hormone Center, Tampa, FL, USA.

European Journal of Clinical Investigation
|June 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kinetics of <i>HTT</i> lowering in brain of YAC 128 mice following single and repetitive intranasal dosing of siRNA packaged in chitosan-based nanoparticle.

Journal of drug delivery science and technology·2021
Same author

The expression of the transcription factor TAF1 is modified by the HPV16 E2 protein.

Acta virologica·2020
Same author

Human Umbilical Cord Cells Express Neural Markers after Transplantation into Subventricular Zone of the DevelopingRat Brain.

Cell transplantation·2017
Same author

Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours.

The International journal of neuroscience·2011
Same author

Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.

European journal of clinical investigation·2010
Same author

Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.

Neuroscience·2009
Same journal

Pacemaker Status and 5-Year Mortality After TAVI: A Sex-Specific Analysis.

European journal of clinical investigation·2026
Same journal

Causal Effects of Time-Varying Treatments: The G-Formula.

European journal of clinical investigation·2026
Same journal

Improving Scientific Research: Renegotiated Principles of Science, Proposals, Failures, and Successes.

European journal of clinical investigation·2026
Same journal

Beta-Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta-Analysis With Trial Sequential Analysis.

European journal of clinical investigation·2026
Same journal

Prognostic Role of Serum Albumin Levels in Elderly Patients With Non-Valvular Atrial Fibrillation.

European journal of clinical investigation·2026
Same journal

Circulating Human Epididymis Protein 4 Predicts 10-Year Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Artery Disease.

European journal of clinical investigation·2026
See all related articles

Five peptide hormones, including vessel dilator and atrial natriuretic peptide (ANP), effectively reduce small-cell lung cancer cells and inhibit proliferation by decreasing DNA synthesis. These findings suggest potential therapeutic applications for natriuretic peptides in lung cancer treatment.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Four peptide hormones from a family of six demonstrated efficacy in reducing adenocarcinoma cells in vitro.
  • Previous research indicated natriuretic peptides' anti-proliferative effects on certain cancer cell types.

Purpose of the Study:

  • To investigate the efficacy of six peptide hormones in reducing small-cell lung cancer (SCLC) cell numbers and proliferation.
  • To determine if the anti-cancer effects of these peptide hormones extend beyond adenocarcinomas to SCLC.

Main Methods:

  • Human SCLC cells were cultured and treated with six peptide hormones for 24, 48, 72, and 96 hours.
  • Cell number, proliferation, and DNA synthesis were assessed. Receptor expression (natriuretic peptide receptors A and C) was analyzed via Western blot.

Related Experiment Videos

Main Results:

  • Vessel dilator, long acting natriuretic peptide (LANP), kaliuretic peptide, and atrial natriuretic peptide (ANP) significantly decreased SCLC cell numbers and DNA synthesis within 24 hours.
  • Brain natriuretic peptide (BNP) and C-natriuretic peptide (CNP) showed limited effects at lower concentrations, but CNP demonstrated efficacy at higher concentrations.
  • Natriuretic peptide receptors A and C were detected in SCLC cells, suggesting a potential mechanism of action.

Conclusions:

  • Five peptide hormones significantly reduce SCLC cell numbers and inhibit proliferation for up to 96 hours.
  • The mechanism involves the inhibition of DNA synthesis, partly mediated by cyclic GMP.
  • These findings highlight the potential of specific natriuretic peptides as therapeutic agents for small-cell lung cancer.